148 related articles for article (PubMed ID: 4045496)
1. Blood acetyl- and butyrylcholinesterases in senile dementia of Alzheimer type.
Atack JR; Perry EK; Perry RH; Wilson ID; Bober MJ; Blessed G; Tomlinson BE
J Neurol Sci; 1985 Aug; 70(1):1-12. PubMed ID: 4045496
[TBL] [Abstract][Full Text] [Related]
2. Blood markers in Alzheimer disease: subnormal acetylcholinesterase and butyrylcholinesterase in lymphocytes and erythrocytes.
Inestrosa NC; Alarcón R; Arriagada J; Donoso A; Alvarez J; Campos EO
J Neurol Sci; 1994 Mar; 122(1):1-5. PubMed ID: 8195795
[TBL] [Abstract][Full Text] [Related]
3. Cholinesterase activity in plasma, erythrocytes, and cerebrospinal fluid of patients with dementia of the Alzheimer type.
Marquis JK; Volicer L; Mark KA; Direnfeld LK; Freedman M
Biol Psychiatry; 1985 Jun; 20(6):605-10. PubMed ID: 3995108
[TBL] [Abstract][Full Text] [Related]
4. Altered lymphocyte acetylcholinesterase activity in patients with senile dementia.
Bartha E; Szelényi J; Szilágyi K; Venter V; Thu Ha NT; Páldi-Haris P; Hollán S
Neurosci Lett; 1987 Aug; 79(1-2):190-4. PubMed ID: 3499586
[TBL] [Abstract][Full Text] [Related]
5. Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease.
Sirviö J; Kutvonen R; Soininen H; Hartikainen P; Riekkinen PJ
J Neural Transm; 1989; 75(2):119-27. PubMed ID: 2918304
[TBL] [Abstract][Full Text] [Related]
6. Status of cholinesterase activities in blood in neuropsychiatric disorders.
Deutsch SI; Campbell M
Neurochem Res; 1984 Jul; 9(7):863-9. PubMed ID: 6390233
[TBL] [Abstract][Full Text] [Related]
7. Low Plasma Cholinesterase Activities are Associated with Deficits in Spatial Orientation, Reduced Ability to Perform Basic Activities of Daily Living, and Low Body Mass Index in Patients with Progressed Alzheimer's Disease.
Dingova D; Fazekas T; Okuliarova P; Strbova J; Kucera M; Hrabovska A
J Alzheimers Dis; 2016; 51(3):801-13. PubMed ID: 26890780
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type.
Atack JR; May C; Kaye JA; Kay AD; Rapoport SI
Ann Neurol; 1988 Feb; 23(2):161-7. PubMed ID: 3377438
[TBL] [Abstract][Full Text] [Related]
9. Plasma and erythrocyte acetylcholinesterase in senile dementia of Alzheimer type.
Perry RH; Wilson ID; Bober MJ; Atack J; Blessed G; Tomlinson BE; Perry EK
Lancet; 1982 Jan; 1(8264):174-5. PubMed ID: 6119555
[No Abstract] [Full Text] [Related]
10. Activities and kinetic properties of lumbar cerebrospinal fluid cholinesterases in relation to clinical diagnosis, severity, and progression of Alzheimer's disease.
Huff FJ; Reiter CT; Protetch J
Can J Neurol Sci; 1989 Nov; 16(4):406-10. PubMed ID: 2804802
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte acetylcholinesterase as biomarker of pesticide exposure: new and forgotten insights.
Assis CRD; Linhares AG; Cabrera MP; Oliveira VM; Silva KCC; Marcuschi M; Maciel Carvalho EVM; Bezerra RS; Carvalho LB
Environ Sci Pollut Res Int; 2018 Jul; 25(19):18364-18376. PubMed ID: 29797194
[TBL] [Abstract][Full Text] [Related]
12. Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid.
Atack JR; Perry EK; Bonham JR; Perry RH
J Neurochem; 1987 Jun; 48(6):1845-50. PubMed ID: 3572402
[TBL] [Abstract][Full Text] [Related]
13. Changes in brain cholinesterases in senile dementia of Alzheimer type.
Perry EK; Perry RH; Blessed G; Tomlinson BE
Neuropathol Appl Neurobiol; 1978; 4(4):273-7. PubMed ID: 703927
[TBL] [Abstract][Full Text] [Related]
14. Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers.
Ben Anes A; Ben Nasr H; Garrouch A; Bennour S; Bchir S; Hachana M; Benzarti M; Tabka Z; Chahed K
Mol Cell Biochem; 2018 Aug; 445(1-2):1-11. PubMed ID: 29234928
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term aluminum feeding on kinetics attributes of tissue cholinesterases.
Dave KR; Syal AR; Katyare SS
Brain Res Bull; 2002 Jun; 58(2):225-33. PubMed ID: 12127022
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.
Ruberg M; Villageois A; Bonnet AM; Pillon B; Rieger F; Agid Y
J Neurol Neurosurg Psychiatry; 1987 May; 50(5):538-43. PubMed ID: 2953866
[TBL] [Abstract][Full Text] [Related]
17. [The activity of blood serum cholinesterases and neprilysin as potential biomarkers of mild-cognitive impairment and Alzheimer's disease].
Zhuravin IА; Nalivaeva NN; Kozlova DI; Kochkina EG; Fedorova YB; Gavrilova SI
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):110-117. PubMed ID: 26978503
[TBL] [Abstract][Full Text] [Related]
18. Comparison of methods used for the determination of cholinesterase activity in whole blood.
Naik RS; Doctor BP; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):298-302. PubMed ID: 18555980
[TBL] [Abstract][Full Text] [Related]
19. [Interest of the cholinesterase assay during organophosphate poisonings].
Jalady AM; Dorandeu F
Ann Fr Anesth Reanim; 2013 Dec; 32(12):856-62. PubMed ID: 24209986
[TBL] [Abstract][Full Text] [Related]
20. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
Haigh JR; Johnston SR; Peppernay A; Mattern PJ; Garcia GE; Doctor BP; Gordon RK; Aisen PS
Chem Biol Interact; 2008 Sep; 175(1-3):380-6. PubMed ID: 18572153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
